Mesoblast Limited’s FDA-approved Ryoncil and advancing Revascor target major conditions like SR-aGVHD and heart failure. See ...

A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...

Identifying a heart attack and utilizing these life-saving tips will equip you with the knowledge you need to handle a ...

Many heart attack survivors experience symptoms similar to those who have lived through traumatic incidents. Flashbacks, ...

On a recent afternoon, sisters Ashia Abraham and Kayla Labbe giggle as they feed Ashia’s 10-month-old daughter in her high ...

Launched in 2021, the American Heart Association’s three-year quality improvement initiative was designed to drive the uptake ...

The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

About 6.7 million adults in the U.S. are living with heart failure, and that number is expected to increase to more than 8 million by 2030.

A new gene therapy reversed heart failure in pigs by repairing heart function through cBIN1, showing major promise for future ...

Clots are treated with blood thinners. But the length of treatment depends on the causes behind a clot, which is categorized as either provoked or unprovoked. A provoked clot is one from a known ...

The Conversation reports on research that even though most Americans don't know the normal or healthy range for blood ...